All living cells are separated from their extracellular environment by a plasma membrane. Whereas gram-negative and gram-positive bacteria have a plasma membrane composed of phospholipids, gram-negative bacteria also possess an outer membrane containing phospholipids in its inner leaflet and lipopolysaccharides (LPS) in its outer leaflet (12) . Because phospholipid biosynthesis in bacterial cells occurs on the inner leaflet of the plasma membrane by integral enzymes whose catalytic site is directed toward the cytoplasm (9, 23, 29) , membrane transporters must be present that mediate the flipping of the newly synthesized lipids from the inner leaflet to the outer leaflet during the biogenesis of the plasma membrane. In addition, mechanisms must exist in gram-negative bacteria that allow trafficking of lipids from the plasma membrane to the outer membrane.
One of the recently discovered lipid transporters in the gram-negative Escherichia coli is the ATP-binding cassette (ABC) transporter MsbA. This transporter was the first ABC efflux system for which high-resolution crystal structures were obtained (4, 5, 25) . MsbA is essential for cell viability, probably by mediating the transport of the lipid A core moiety of LPS from the cytoplasmic membrane to the outer membrane, where this lipid functions as the hydrophobic anchor of LPS (8, 37) . LPS is active as an endotoxin in mammals as it activates macrophages to produce cytokines and inflammatory mediators (18, 21) . The msbA gene was first discovered as a multicopy suppressor of mutations in htrB, which encodes a protein involved in the synthesis of LPS. Overexpression of msbA was shown to complement the htrB phenotype by restoring transport of immature LPS precursors (13) . Conditional E. coli mutants in which MsbA-dependent LPS transport or early steps of lipid A biosynthesis can be switched off lose several logs of viability in 3 to 4 h (8, 11, 37) . Reduced LPS biosynthesis also renders E. coli hypersensitive to antibiotics (36) due, in part, to a loss of integrity of the outer membrane, which is a main barrier for drug influx into the cell (19) . Consistent with the coupling between ATP hydrolysis and substrate transport in other ABC transporters (30) , the MsbA-associated ATPase activity is stimulated by free hexa-acylated lipid A, produced by the mild acid hydrolysis of isolated LPS (7) . Although MsbA was also implicated in the transport of phospholipids to the outer membrane (8, 37) , recent work with Neisseria meningitidis (3) and E. coli (28) suggests that phospholipids and LPS may follow different routes to the outer membrane and that the transport of phospholipids may be MsbA independent (3, 14) .
Previous studies suggested that MsbA and the multidrug transporter LmrA, an MsbA homologue in the gram-positive Lactococcus lactis (31, 34) , might have overlapping substrate specificities. LmrA mediates the transport of fluorescent lipid analogues and exhibits a free-lipid-A-stimulated ATPase activity (15, 24) . LmrA could also functionally substitute for a temperature-sensitive mutant form of MsbA in E. coli WD2 cells at nonpermissive temperatures, pointing to LmrA-mediated transport of LPS in this E. coli strain (24) . Reciprocally, MsbA was suggested to interact with multiple drugs in E. coli Protein cross-linking. Cross-linking studies with MsbA were performed using inside-out membrane vesicles (25 g membrane protein) in 50 mM potassium phosphate (pH 7.0). Inside-out membrane vesicles were incubated for 30 min at 30°C in the presence of 0.1 mM DSP [dithio-bis(succinimidyl propionate)] (Pierce, Cheshire, United Kingdom). Samples were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting using the monoclonal antipentahistidine antibody (QIAGEN).
Hoechst 33342 transport. Hoechst transport was measured essentially as described previously (22) . Inside-out membrane vesicles (0.25 mg protein) were resuspended in 2 ml of 50 mM potassium phosphate (pH 7.0) supplemented with 5 mM MgSO 4 , 5 mM phosphocreatine, and 0.1 mg/ml creatine kinase. Hoechst 33342 (Molecular Probes, Leiden, The Netherlands) was added to final concentrations between 0.03 M to 0.60 M, as indicated in Fig. 3 and 6 . After a steady-state level of Hoechst 33342 fluorescence was obtained, 2 mM Mg-ATP was added to initiate its transport. The rate of Hoechst 33342 transport was measured over the first 60 s, during which the fluorescence decrease was linear. Vinblastine (in methanol) and free lipid A (in dimethyl sulfoxide) were used in the experiments in Fig. 6A and C to final volumes of 0.5% and 2.5%, respectively. Samples without inhibitor received the solvent only. Measurements were performed in an LS-55B luminescence spectrometer at excitation and emission wavelengths of 355 nm and 457 nm, respectively, and slit widths of 5 and 10 nm, respectively. Photoaffinity labeling.
[ 3 H]azidopine labeling of MsbA was performed in inside-out membrane vesicles by previously described methods (24) . The inhibition of [ 3 H]azidopine labeling by Hoechst 33342 and nicardipine was evaluated by densitometric analysis following autoradiography.
Curve fitting and statistical analyses. For fitting the transport data to a hyperbolic curve, the Michaelis-
, was used, in which the rate of drug transport is represented by V, the drug concentration by [S] , the maximal transport rate by V max , and the drug concentration yielding 1/2 V max by the Michaelis constant (K m ). The data were also fitted by the
1/n is the average transport constant, and n is the number of ligand binding sites in the ideal case of completely cooperative binding, which is estimated experimentally by the Hill number (n Hill ). In cytotoxicity assays, m was estimated from growth curves by fitting the data to N t ϭ N 0 ϫ e m ϫ t , in which N t and N 0 are the cell densities at times t and 0 h, respectively. All statistical analyses were based on four independent observations (n ϭ 4), unless indicated otherwise, using different batches of cells or membrane vesicles. The statistical analyses were made using Student's t test with a 95% confidence interval for the sample mean.
RESULTS
Expression of MsbA in Lactococcus lactis. For the expression of MsbA in L. lactis NZ9000, msbA was cloned into the lactococcal expression vector pNZ8048 (6) under the control of the nisin A-inducible nisA promoter. This expression system had previously been used for the expression of LmrA in L. lactis (15) . The addition of 10 pg/ml nisin A to exponentially growing L. lactis cells harboring pNZMsbA resulted in the expression of the MsbA polypeptide at a level of 20 to 30% of total membrane protein, as determined by densitometric analysis of a Coomassie brilliant blue-stained SDS-PAGE gel (Fig. 1A) . MsbA was undetectable in control cells harboring the pNZ8048 control vector, when incubated in the presence of nisin A.
Similar to LmrA, MsbA is a half-transporter consisting of an amino-terminal transmembrane domain with six transmembrane-spanning segments followed by the nucleotide-binding domain. LmrA is functional as a homodimer as suggested by the negative dominance of a transport-inactive LmrA mutant over the transport-active wild-type LmrA protein in a coreconstituted liposomal system and by the observation that the covalent fusion of two wild-type LmrA monomers yields a functional transporter (33) . To test if MsbA forms a dimer in L. lactis, inside-out membrane vesicles containing MsbA were exposed to the chemical cross-linker dithio-bis(succinimidyl propionate), which reacts covalently with primary and secondary amines. As shown on an immunoblot (Fig. 1B) , dimeric and higher oligomeric forms of MsbA were detectable after crosslinking.
Heterologously expressed MsbA confers drug resistance on cells. In initial studies with L. lactis the interaction between MsbA and drugs was studied by photoaffinity labeling experiments. In agreement with our previous observations with E. coli (24) , MsbA could be photoaffinity labeled with the 1,4-dihydropyridine derivative 3 [H]azidopine (Fig. 1C) . The photo-cross-linking reaction was inhibited by Hoechst 33342 and the 1,4-dihydropyridine nicardipine, a modulator of the human multidrug resistance P-glycoprotein (ABCB1) (31), with concentrations giving 50% inhibition of about 38 M and 9 M, respectively (Fig. 1C) . As L. lactis exhibits an enhanced drug sensitivity compared to E. coli due to the lack of an outer membrane, we performed cytotoxicity assays to examine the drug transport activity of MsbA in the lactococcal cells. In these assays, cells were exposed to a reduced concentration of the inducer nisin A (1 pg/ml) to maintain a m in the absence of drug as observed for the nonexpressing control (Fig. 2) . The concentration of erythromycin necessary to reduce the m of L. lactis by 50% (IC 50 ) was significantly increased from 0.3 Ϯ 0.1 g/ml in the nonexpressing control to 25.8 Ϯ 0.6 g/ml in MsbA-expressing cells (n ϭ 3), giving a relative resistance factor (IC 50 for MsbA-expressing cells/IC 50 for control cells) of 86 (Fig. 2) . MsbA-mediated erythromycin resistance was completely reversed by the vinca alkaloid vinblastine, a P-glycoprotein substrate that is nontoxic to L. lactis at the 20 M concentration used (Fig. 2) . Interestingly, compared to the control, the expression of MsbA in L. lactis was also associated To study the interaction of heterologously expressed MsbA with drugs, the transport of Hoechst 33342 by MsbA was studied in lactococcal inside-out membrane vesicles in which the nucleotide-binding domain of MsbA was exposed on the outside surface of the membrane. The addition of Hoechst 33342 resulted in a rapid increase in fluorescence up to a steady-state level due to the partitioning of the dye in the hydrophobic environment of the phospholipid bilayer (Fig. 3A) . The subsequent addition of Mg-ATP resulted in a rapid quenching of the Hoechst 33342 fluorescence in membrane vesicles containing MsbA compared to control membrane vesicles (Fig. 3A) , reflecting the MsbA-mediated transport of Hoechst 33342 into the lumen of the membrane vesicles. The initial rate of Hoechst 33342 transport was measured between 0.03 M and 0.6 M Hoechst 33342, well within the concentration range at which the fluorescence of Hoechst 33342 and its partitioning into the phospholipid bilayer increase linearly with the total amount of Hoechst 33342 added (22) . Figure 3B shows that the MsbA-mediated transport of Hoechst 33342 increased in a saturable fashion with the concentration of Hoechst 33342. The transport data could be fitted well to a hyperbola with a correlation coefficient (R 2 ) of 0.980, K m (affinity for substrate) of 0.20 Ϯ 0.05 M, and V max of 0.37 Ϯ 0.03 arbitrary units (a.u.)/s (Table 1) . To enable a direct comparison of MsbA and LmrA, the transport experiments were also repeated with LmrA-containing inside-out membrane vesicles (Fig. 3B) . Similar to MsbA, the Hoechst transport data for LmrA could be well fitted to a hyperbola ( Transport of ethidium. To obtain further support for MsbAmediated drug transport, the effect of the expression level of MsbA on ethidium transport was tested. For this purpose, MsbA expression in L. lactis was induced at a nisin A concentration of 10 pg/ml (standard for transport assays) or 0.67 pg/ml, yielding high-MsbA-expressing and low-MsbA-expressing cells, respectively. The difference between the expression levels of MsbA under these conditions was confirmed by immunoblotting (Fig. 4, inset) . The addition of 20 mM glucose to ATP-depleted cells, which were preequilibrated with 2 M ethidium, elicited a significant reduction of ethidium fluorescence in high-MsbA-expressing cells compared to the nonexpressing control, reflecting drug efflux. Ethidium efflux was reduced in low-MsbA-expressing cells, whereas, in the absence of MsbA expression, ethidium uptake was observed upon the addition of ATP due to the transmembrane potential (interior negative)-driven passive influx of the cationic dye in the absence of MsbA-mediated efflux (Fig. 4) . As mutations that inactivate ATP hydrolysis by the nucleotide-binding domain of MsbA completely block ethidium efflux in MsbA-expressing lactococcal cells, the enhanced expression of MsbA does not appear to upregulate the activity of endogenous multidrug transporters in L. lactis (data not shown). In previous work, it was shown that the MsbA homologue LmrA is a reversible efflux system that can mediate drug uptake under ATP-depleted conditions (2, 26, 35) . Similar to LmrA, MsbA mediated ethidium uptake in ATP-depleted cells down the ethidium concentration gradient (data not shown). The major advantage of measuring MsbA-mediated drug uptake rather than drug efflux is that (i) the drug concentration at the side from which transport occurs, the extracellular buffer, can be carefully controlled, and (ii) the initial rate of ethidium uptake is measured under conditions where the cytosolic ethidium concentration is essentially zero. The kinetic parameters of MsbA-mediated ethidium uptake were analyzed in detail by measuring the initial rate of uptake as a function of the external ethidium concentrations between 1 and 25 M (Fig. 5A) . The data fitted to a hyperbola with an R 2 of 0.959, yielding an apparent K m of 4.8 Ϯ 1.4 M and V max of 0.28 Ϯ 0.03 a.u./s (Table 1) . These kinetic parameters are comparable to those observed for LmrA in a previous study (2) . Figure 5B shows that, when the uptake reaction has reached equilibrium, the ethidium fluorescence increases linearly with the total ethidium concentration up to a concentration of at least 30 M. Hence, the observed V max cannot be explained by saturation of DNA by ethidium or by self-quenching of ethidium.
Drug interactions on MsbA. The evidence obtained with L. lactis suggests the presence of binding sites in MsbA for azidopine (Fig. 1) , erythromycin and vinblastine (Fig. 2) , Hoechst 33342 (Fig. 3) , and ethidium (Fig. 4 and 5 ). Experiments were performed to examine if and how these drug-binding sites interact. The kinetics of MsbA-mediated Hoechst 33342 transport in inside-out membrane vesicles was determined in the presence of fixed concentrations of vinblastine. The results obtained (Fig. 6A) showed that the K m for MsbA-mediated Hoechst 33342 transport increased at increasing vinblastine concentrations, whereas the V max remained unaltered. The Lineweaver-Burk plots (Fig. 6A) Table 1) . Vinblastine also competitively inhibited MsbA-mediated uptake of ethidium in ATP-depleted cells with an apparent K i value of 11 Ϯ 3 M ( Fig. 6B; Table 1 ), suggesting the binding of vinblastine and ethidium to a common binding site. Erythromycin/ethidium, erythromycin/Hoechst 33342, and ethidium/Hoechst 33342 mixtures were not compatible in the fluorescence-based transport assays as interference was observed with the intrinsic drug fluorescence and/or drug partitioning in the phospholipid bilayer. Therefore, no attempts were made to study possible interactions between drug-binding sites for these substrates.
We 
DISCUSSION
In a previous study with E. coli, we described our first evidence for the ability of MsbA to interact with multiple drugs (24) . One complicating factor in further studies on MsbAmediated drug transport in E. coli is that MsbA indirectly supports TolC-dependent multidrug transporters, such as the AcrA/B system, which extrudes drugs across the outer membrane (19) , by maintaining the integrity of the outer membrane (36) . It is, therefore, not so straightforward to separate MsbAmediated drug transport and MsbA-supported drug transport in intact E. coli cells. Another complicating factor is the possible inhibition of MsbA-mediated drug transport in E. coli by the lipid A core moiety of LPS; we show in this paper that this interaction is indeed relevant. To bypass these difficulties, we expressed MsbA in L. lactis and studied the drug transport activity of the protein in the absence of LPS and an E. coli-like periplasm and outer membrane.
The expression of MsbA in lactococcal cells conferred an 86-fold increase in resistance to erythromycin (Fig. 2 ) and a small, but significant, increase in the IC 50 in the presence of specific toxic fatty acids and monoglyceride lipids compared to nonexpressing control cells. These results are particularly relevant in view of the low-MsbA-expressing conditions used in the cell cytotoxicity assays. The MsbA-associated drug resistance was based on an efflux mechanism, as ATP-dependent Hoechst 33342 transport was detected in MsbA-containing inside-out membrane vesicles. In addition, active ethidium extrusion was observed in MsbA-containing cells compared to the nonexpressing controls, the rate of which was affected by the expression level of MsbA (Fig. 4) . In related work (26) , we demonstrated that the ethidium fluorescence decrease observed during efflux coincides with the physical movement of ethidium to the extracellular buffer. MsbA could also be photoaffinity labeled with azidopine and protected from photolabeling by Hoechst 33342 and nicardipine (Fig. 1) . Taken together, these findings demonstrate the ability of MsbA to interact with multiple drugs in L. lactis.
Measurement of the rate of MsbA-mediated transport of Hoechst 33342 and ethidium as a function of the drug concentration revealed apparent single-site transport kinetics with K m values comparable to those observed for LmrA ( Fig. 3B and 5 ; Table 1 ). However, it should be noted that for the kinetic data concerning ethidium transport (Fig. 5 ) a reasonable fit could also be obtained using a sigmoidal curve, giving an R 2 of 0.995, K t of 3.12 Ϯ 0.31 M, V max of 0.23 Ϯ 0.01 a.u./s, and n Hill of 1.9 Ϯ 0.3. The quality of the fit obtained with the sigmoidal curve was also apparent from an analysis of the residual variance, which indicated a 4.3-fold-smaller sum of squares of the vertical distances of the data from the predicted line for the sigmoidal curve compared to the hyperbola (6.1 ϫ 10 Ϫ4 versus 2.6 ϫ 10 Ϫ3 ). In addition, the regression analyses revealed a standard error of the estimate (a measure of the actual variability about the regression plane of the underlying experimental data) of 0.0102 for the sigmoidal curve versus 0.0198 for the hyperbola. Interestingly, the n Hill for ethidium of about 1.9 suggests homotropic interactions between two (or more) binding sites for ethidium and would be consistent with (i) previous vinblastine equilibrium binding studies on LmrA pointing to two interacting, nonidentical vinblastine-binding sites in dimeric LmrA (33) , (ii) photoaffinity labeling/mass spectrometry analyses of LmrA and the mammalian MsbA homologue P-glycoprotein MDR1 (ABCB1), suggesting drug labeling at the two transmembrane domain/transmembrane domain interfaces formed between the two half-transporters in P-glycoprotein and dimeric LmrA (10, 20) , and (iii) the recent 4.2-Å resolution crystal structure for Salmonella enterica serovar Typhimurium MsbA, showing that each monomer in the homodimer contains a binding site for rough-chemotype LPS (25) . A large body of evidence exists for the presence of two or more nonidentical transport-competent drug-binding sites in P-glycoprotein (1, 16, 17 ; see references 30 and 32 for reviews). If similar sites are present in MsbA, Hoechst 33342 might interact with only one of these drug-binding sites, giving rise to single-site kinetics for this substrate (Fig. 3B) . The small deviation of the ethidium transport data from the fitted hyperbola in favor of the sigmoidal curve at concentrations around 1 M ethidium (Fig. 5 ) might also reflect a nonlinearity between the initial ethidium transport rate and the association/dissociation of the fluorescent ethidium-DNA complex, which is the monitored parameter in the assay. We further analyzed MsbAmediated ethidium transport using the simplest (single-site) model. We studied the mechanism by which drugs and free lipid A interact on MsbA and obtained evidence for the competitive inhibition of ethidium and Hoechst 33342 transport by vinblastine ( Fig. 6A and B) . Vinblastine also inhibited MsbA-mediated erythromycin transport, although the mechanism of this inhibition was not studied in detail (Fig. 2) . Interestingly, we observed an inhibition of MsbA-mediated Hoechst 33342 transport by free lipid A, which is based on a simple noncompetitive mechanism (Fig. 6C ). Drugs and free lipid A stimulate the vanadate-sensitive MsbA-ATPase in E. coli (7, 24) . As the vanadate-sensitive MsbA-ATPase was also stimulated two-to threefold by these substrates in lactococcal membranes, the simple noncompetitive inhibition might indicate that the binding of Hoechst 33342 and free lipid A to separate sites on MsbA can induce an ATP-dependent transport reaction, when bound individually or together, but that transport reactions involving free lipid A occur at a much lower rate than the reaction involving Hoechst 33342 only. Noncompetitive drug interactions have been observed for a variety of multidrug transporters ranging from the human P-glycoprotein (1, 17) to the lactococcal multidrug/proton antiporter LmrP (22) . The inhibition of Hoechst 33342 transport by free lipid A underscores the relevance of our LPS-less lactococcal model for studies on MsbA-mediated drug transport. Our findings might show analogy to previous studies on the canalicular phosphatidylcholine transporter MDR3 (ABCB3). This mammalian homologue of MsbA transports several anticancer drugs when heterologously expressed in insect cells but is much less effective in drug transport in transfected mammalian cell lines or in vivo at the canalicular membrane due to the presence of phosphatidylcholine in the local environment of MDR3 in these cells (27) .
Recent evidence points to the translocation of LPS from the inner membrane to the outer membrane in E. coli, at contact sites between these membranes (28) . Although the nature of these contact sites has not yet been established, the sites may be based on interacting proteins in the inner membrane, outer membrane, and periplasm, forming a connecting complex. Although MsbA could be part of this complex, the functional complementation of MsbA by lactococcal LmrA in E. coli (24) , the drug transport activity of purified MsbA in proteoliposomes (24) , and the drug transport activity of MsbA in intact L. lactis cells in the absence of auxiliary E. coli proteins (this work) argue that the drug transport activity of MsbA is at least partially retained outside of the environment of a connecting complex.
In conclusion, our investigations on E. coli MsbA demonstrate the ability of this protein to interact with free lipid A and multiple drugs in the absence of auxiliary E. coli proteins. These findings provide further functional support for direct LPS-MsbA interactions as observed in a recent crystal structure for MsbA from S. enterica serovar Typhimurium (25) . MsbA expression in LPS-deficient L. lactis offers a useful tool for more detailed biochemical studies.
